Dis-Chem Pharmacies Limited

JSE:DCP Stock Report

Market Cap: R31.5b

Dis-Chem Pharmacies Dividends and Buybacks

Dividend criteria checks 0/6

Dis-Chem Pharmacies is a dividend paying company with a current yield of 1.35%.

Key information

1.3%

Dividend yield

0.05%

Buyback Yield

Total Shareholder Yield1.4%
Future Dividend Yield2.1%
Dividend Growth10.7%
Next dividend pay daten/a
Ex dividend daten/a
Dividend per shareR0.495
Payout ratio40%

Recent dividend and buyback updates

Recent updates

Is Dis-Chem Pharmacies (JSE:DCP) Using Too Much Debt?

Nov 27
Is Dis-Chem Pharmacies (JSE:DCP) Using Too Much Debt?

Shareholders Are Optimistic That Dis-Chem Pharmacies (JSE:DCP) Will Multiply In Value

Nov 10
Shareholders Are Optimistic That Dis-Chem Pharmacies (JSE:DCP) Will Multiply In Value

These 4 Measures Indicate That Dis-Chem Pharmacies (JSE:DCP) Is Using Debt Reasonably Well

Aug 21
These 4 Measures Indicate That Dis-Chem Pharmacies (JSE:DCP) Is Using Debt Reasonably Well

Shareholders Should Be Pleased With Dis-Chem Pharmacies Limited's (JSE:DCP) Price

Jun 06
Shareholders Should Be Pleased With Dis-Chem Pharmacies Limited's (JSE:DCP) Price

Dis-Chem Pharmacies (JSE:DCP) Will Be Hoping To Turn Its Returns On Capital Around

Apr 17
Dis-Chem Pharmacies (JSE:DCP) Will Be Hoping To Turn Its Returns On Capital Around

Dis-Chem Pharmacies (JSE:DCP) Seems To Use Debt Quite Sensibly

Feb 26
Dis-Chem Pharmacies (JSE:DCP) Seems To Use Debt Quite Sensibly

Dis-Chem Pharmacies (JSE:DCP) Might Be Having Difficulty Using Its Capital Effectively

Dec 30
Dis-Chem Pharmacies (JSE:DCP) Might Be Having Difficulty Using Its Capital Effectively

If EPS Growth Is Important To You, Dis-Chem Pharmacies (JSE:DCP) Presents An Opportunity

Sep 07
If EPS Growth Is Important To You, Dis-Chem Pharmacies (JSE:DCP) Presents An Opportunity

Here's Why Dis-Chem Pharmacies (JSE:DCP) Can Manage Its Debt Responsibly

Aug 16
Here's Why Dis-Chem Pharmacies (JSE:DCP) Can Manage Its Debt Responsibly

Dis-Chem Pharmacies (JSE:DCP) Will Want To Turn Around Its Return Trends

Jul 31
Dis-Chem Pharmacies (JSE:DCP) Will Want To Turn Around Its Return Trends

Is Now The Time To Put Dis-Chem Pharmacies (JSE:DCP) On Your Watchlist?

May 09
Is Now The Time To Put Dis-Chem Pharmacies (JSE:DCP) On Your Watchlist?

There Are Reasons To Feel Uneasy About Dis-Chem Pharmacies' (JSE:DCP) Returns On Capital

Mar 29
There Are Reasons To Feel Uneasy About Dis-Chem Pharmacies' (JSE:DCP) Returns On Capital

Is Now The Time To Put Dis-Chem Pharmacies (JSE:DCP) On Your Watchlist?

Jan 14
Is Now The Time To Put Dis-Chem Pharmacies (JSE:DCP) On Your Watchlist?

Returns On Capital At Dis-Chem Pharmacies (JSE:DCP) Paint A Concerning Picture

Nov 04
Returns On Capital At Dis-Chem Pharmacies (JSE:DCP) Paint A Concerning Picture

Dis-Chem Pharmacies Limited (JSE:DCP) Shares Could Be 24% Below Their Intrinsic Value Estimate

Oct 04
Dis-Chem Pharmacies Limited (JSE:DCP) Shares Could Be 24% Below Their Intrinsic Value Estimate

We Ran A Stock Scan For Earnings Growth And Dis-Chem Pharmacies (JSE:DCP) Passed With Ease

Sep 01
We Ran A Stock Scan For Earnings Growth And Dis-Chem Pharmacies (JSE:DCP) Passed With Ease

Some Investors May Be Worried About Dis-Chem Pharmacies' (JSE:DCP) Returns On Capital

Jul 04
Some Investors May Be Worried About Dis-Chem Pharmacies' (JSE:DCP) Returns On Capital

A Look At The Fair Value Of Dis-Chem Pharmacies Limited (JSE:DCP)

Jun 21
A Look At The Fair Value Of Dis-Chem Pharmacies Limited (JSE:DCP)

Dis-Chem Pharmacies (JSE:DCP) Has A Pretty Healthy Balance Sheet

Jun 08
Dis-Chem Pharmacies (JSE:DCP) Has A Pretty Healthy Balance Sheet

The Dis-Chem Pharmacies Limited (JSE:DCP) Yearly Results Are Out And Analysts Have Published New Forecasts

May 25
The Dis-Chem Pharmacies Limited (JSE:DCP) Yearly Results Are Out And Analysts Have Published New Forecasts

Is Dis-Chem Pharmacies (JSE:DCP) A Risky Investment?

Feb 23
Is Dis-Chem Pharmacies (JSE:DCP) A Risky Investment?

Dis-Chem Pharmacies Limited's (JSE:DCP) Price In Tune With Earnings

Feb 08
Dis-Chem Pharmacies Limited's (JSE:DCP) Price In Tune With Earnings

I Ran A Stock Scan For Earnings Growth And Dis-Chem Pharmacies (JSE:DCP) Passed With Ease

Dec 13
I Ran A Stock Scan For Earnings Growth And Dis-Chem Pharmacies (JSE:DCP) Passed With Ease

Dis-Chem Pharmacies' (JSE:DCP) Strong Earnings Are Of Good Quality

Nov 09
Dis-Chem Pharmacies' (JSE:DCP) Strong Earnings Are Of Good Quality

Stability and Growth of Payments

Fetching dividends data

Stable Dividend: DCP is not paying a notable dividend for the ZA market, therefore no need to check if payments are stable.

Growing Dividend: DCP is not paying a notable dividend for the ZA market, therefore no need to check if payments are increasing.


Dividend Yield vs Market

Dis-Chem Pharmacies Dividend Yield vs Market
How does DCP dividend yield compare to the market?
SegmentDividend Yield
Company (DCP)1.3%
Market Bottom 25% (ZA)3.2%
Market Top 25% (ZA)7.8%
Industry Average (Consumer Retailing)2.3%
Analyst forecast (DCP) (up to 3 years)2.1%

Notable Dividend: DCP's dividend (1.35%) isn’t notable compared to the bottom 25% of dividend payers in the ZA market (3.19%).

High Dividend: DCP's dividend (1.35%) is low compared to the top 25% of dividend payers in the ZA market (7.83%).


Earnings Payout to Shareholders

Earnings Coverage: DCP is not paying a notable dividend for the ZA market.


Cash Payout to Shareholders

Cash Flow Coverage: DCP is not paying a notable dividend for the ZA market.


Discover strong dividend paying companies

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/23 04:05
End of Day Share Price 2024/12/20 00:00
Earnings2024/08/31
Annual Earnings2024/02/29

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Dis-Chem Pharmacies Limited is covered by 15 analysts. 6 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Daniel DiasArqaam Capital Research Offshore S.A.L.
Michael de NobregaAvior Capital Markets
Paul Henri SteegersBofA Global Research